Frontiers in neurology

Front Neurol · ISSN (print) 1664-2295 · 4 papers in corpus
other 2026
Migraine epidemiology, comorbidities and therapeutic landscape: a national population-based study
doi:10.3389/fneur.2026.1743203 ·PMID:41668695

BACKGROUND: Migraine is a leading cause of disability worldwide, yet national-level epidemiological data are often lacking, hindering public health planning. This study aimed to provide the first comprehensive, population-based assessment o…

other 2025
Ischemic stroke associated with adenomyosis-related abnormal uterine bleeding: a systematic review of management and outcomes
doi:10.3389/fneur.2025.1698533 ·PMID:41426987

BACKGROUND: Adenomyosis is frequently associated with abnormal uterine bleeding (AUB) and anemia. In the setting of arterial stenosis or hypercoagulability, AUB may precipitate ischemic stroke. However, the optimal management strategy remai…

case-report 2024
Anti-sulfatide antibody-related Guillain-Barré syndrome presenting with overlapping syndromes or severe pyramidal tract damage: a case report and literature review
doi:10.3389/fneur.2024.1360164 ·PMID:38654738

INTRODUCTION: Anti-sulfatide antibodies are key biomarkers for the diagnosis of Guillain-Barré syndrome (GBS). However, case reports on anti-sulfatide antibody-related GBS are rare, particularly for atypical cases. CASE DESCRIPTION CASE 1:…

other 2020
OnabotulinumtoxinA Is an Effective Treatment for Chronic Migraine in Patients With Comorbid Fibromyalgia
doi:10.3389/fneur.2020.575130 ·PMID:33178117

Introduction: Fibromyalgia (FM) is a frequent comorbidity in patients with chronic migraine (CM). PREEMPT trials, which demonstrated the efficacy of OnabotulinumtoxinA (OnabotA) on CM, excluded patients with FM. Our aim was to evaluate the …